Thumbnail image for Amanda Feilding’s speaks at Psychedelic Science 2013

Amanda Feilding’s speaks at Psychedelic Science 2013

May 1, 2013 Beckley in the Media

Read Amanda Feilding’s talk at the Psychedelic Science Conference 2013, held in Oakland California on 18-22 April. The conference was co-hosted by the Beckley Foundation, Multidisciplinary Association for Psychedelic Studies (MAPS), Heffter, and the Council for Spiritual Practices.

Continue Reading →
Thumbnail image for Psychedelic Science Conference 2013

Psychedelic Science Conference 2013

April 26, 2013 Beckley in the Media

The Psychedelic Science conference, co-hosted by the Beckley Foundation, brought together researchers from around the world to discuss research, clinical trials, and medical discoveries involving psychedelic substances. Amanda Feilding presented the results of the Beckley Foundation research programme, including our recent investigations into psilocybin and MDMA.

Continue Reading →
Thumbnail image for Amanda Feilding Interviewed in the Evening Standard

Amanda Feilding Interviewed in the Evening Standard

April 16, 2013 Beckley in the Media

Amanda talks about her life, psilocybin research and all Beckley Foundation projects in this interview with the Evening Standard.

Continue Reading →
Thumbnail image for Government Restrictions Obstruct Crucial Mental Health Research

Government Restrictions Obstruct Crucial Mental Health Research

April 15, 2013 Beckley in the Media

Current drug policies stifle important scientific and clinical research by placing an intolerable burden of regulation on scientists who wish to work with ‘controlled substances’, meaning that very few even try to do so.

Continue Reading →

Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis

October 15, 2012 BF Scientific Publications

A new analysis of the original psilocybin fMRI data has recently been published in a new paper in Schizophrenia Bulletin, in which the psychedelic state is analysed for similarity with early psychosis, as both share similar effects on how different areas of the brain communicate with eachother.

Continue Reading →

Are We Finally Reawakening to the Profound Healing Properties of Psychedelics?

June 18, 2012 MDMA

Legal research on a range of currently illegal drugs indicates they may help cure PTSD, alcoholism and even cluster headaches June 14, 2012  | Slowly but surely, we may be reaching success in a determined and long-time legal effort to unleash the curative powers of psychedelic drugs in America. There is a tremendous need for […]

Continue Reading →

Is the future of drugs safe and non-addictive?

June 11, 2012 Drug abuse

In years to come alcohol may be replaced with happier alternatives and we could all be immunised against developing harmful habits   The next 20 years hold great opportunities for drugs research. We could see the development of pharmacological substitutes, agents to block the effects of drugs and help people break addictions, and drug-based aids […]

Continue Reading →

Psilocybin’s effects on the brain and Aldous Huxley’s ‘reducing valve’ of consciousness: blog reaction to Beckley-Imperial Psilocybin research

January 27, 2012 LSD

In the popular science blog io9, Robert T. Gonzales ties up findings from this week’s Beckley Foundation-Imperial College Psilocybin paper in the PNAS with Aldous Huxley’s ‘reducing valve’ hypothesis, initially presented in his 1954 book The Doors of Perception (http://mescaline.com/huxley.htm); also, to more recent theorising by Karl Friston of University College London (http://www.fil.ion.ucl.ac.uk/~karl/), who postulates, in […]

Continue Reading →

Beckley Foundation-Imperial College collaboration publishes revolutionary research on effects of psilocybin on the brain

January 26, 2012 Press Releases

fMRI brain scans show that psilocybin, the active ingredient in magic mushrooms, lowers the activity of specific brain regions. The finding contradicts the popular belief that psychedelic drugs increase brain activity, and has far reaching implications for the therapeutic use of psilocybin in the treatment of depression and cluster headaches, as well as throwing light […]

Continue Reading →

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

January 3, 2012 BF Scientific Publications

The subjective effects of psychedelic drugs are caused by decreased activity and connectivity in the brain’s key connector hubs, enabling a state of unconstrained cognition.

Continue Reading →